SciVision Biotech Inc (1786) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.026x

Based on the latest financial reports, SciVision Biotech Inc (1786) has a cash flow conversion efficiency ratio of 0.026x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$48.51 Million ≈ $1.53 Million USD) by net assets (NT$1.86 Billion ≈ $58.58 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see SciVision Biotech Inc market capitalisation for the company's overall valuation and market capitalisation.

SciVision Biotech Inc - Cash Flow Conversion Efficiency Trend (2009–2025)

This chart illustrates how SciVision Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

SciVision Biotech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of SciVision Biotech Inc ranked by their cash flow conversion efficiency. Explore 1786 cash to earnings ratio to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
JW Shinyak Corporation KQ:067290	0.115x
Balyo SA PA:BALYO	-1.908x
Thai Plaspac Public Company Limited BK:TPAC	0.071x
Acconeer AB ST:ACCON	-0.079x
Leadtrend Technology Corp TW:3588	0.007x
Bombay Super Hybrid Seeds Limited NSE:BSHSL	0.508x
Definitive Healthcare Corp NASDAQ:DH	0.007x
Supercomnet Technologies Bhd KLSE:0001	0.025x

Annual Cash Flow Conversion Efficiency for SciVision Biotech Inc (2009–2025)

The table below shows the annual cash flow conversion efficiency of SciVision Biotech Inc from 2009 to 2025. View SciVision Biotech Inc share price for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$1.98 Billion ≈ $62.39 Million	NT$123.99 Million ≈ $3.91 Million	0.063x	-55.99%
2024-12-31	NT$1.90 Billion ≈ $59.77 Million	NT$269.87 Million ≈ $8.50 Million	0.142x	-14.94%
2023-12-31	NT$1.63 Billion ≈ $51.24 Million	NT$272.01 Million ≈ $8.57 Million	0.167x	+41.79%
2022-12-31	NT$1.51 Billion ≈ $47.60 Million	NT$178.21 Million ≈ $5.61 Million	0.118x	+73.60%
2021-12-31	NT$1.45 Billion ≈ $45.68 Million	NT$98.51 Million ≈ $3.10 Million	0.068x	-24.57%
2020-12-31	NT$1.40 Billion ≈ $44.24 Million	NT$126.47 Million ≈ $3.98 Million	0.090x	-40.04%
2019-12-31	NT$1.36 Billion ≈ $42.87 Million	NT$204.40 Million ≈ $6.44 Million	0.150x	+44.98%
2018-12-31	NT$1.08 Billion ≈ $33.97 Million	NT$111.70 Million ≈ $3.52 Million	0.104x	+492.97%
2017-12-31	NT$914.45 Million ≈ $28.81 Million	NT$15.98 Million ≈ $503.39K	0.017x	-59.19%
2016-12-31	NT$894.21 Million ≈ $28.17 Million	NT$38.29 Million ≈ $1.21 Million	0.043x	-18.46%
2015-12-31	NT$948.60 Million ≈ $29.89 Million	NT$49.81 Million ≈ $1.57 Million	0.053x	+2800.57%
2014-12-31	NT$1.02 Billion ≈ $32.23 Million	NT$1.85 Million ≈ $58.35K	0.002x	-94.74%
2013-12-31	NT$1.08 Billion ≈ $34.15 Million	NT$37.27 Million ≈ $1.17 Million	0.034x	-71.56%
2012-12-31	NT$425.98 Million ≈ $13.42 Million	NT$51.52 Million ≈ $1.62 Million	0.121x	+18.47%
2011-12-31	NT$363.70 Million ≈ $11.46 Million	NT$37.13 Million ≈ $1.17 Million	0.102x	+66.58%
2010-12-31	NT$111.73 Million ≈ $3.52 Million	NT$6.85 Million ≈ $215.72K	0.061x	+114.28%
2009-12-31	NT$84.09 Million ≈ $2.65 Million	NT$-36.09 Million ≈ $-1.14 Million	-0.429x	--

About SciVision Biotech Inc

TW:1786 Taiwan Medical Instruments & Supplies

Market Cap

$100.20 Million

NT$3.18 Billion TWD

Market Cap Rank

#19281 Global

#1077 in Taiwan

Share Price

NT$43.75

Change (1 day)

+2.34%

52-Week Range

NT$42.75 - NT$110.50

All Time High

NT$136.50